PlainRecalls
FDA Drug Low Class III Terminated

Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03

Reported: July 19, 2023 Initiated: June 27, 2023 #D-0899-2023

Product Description

Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03

Reason for Recall

Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.

Details

Units Affected
3,096 bottles
Distribution
Product was distributed directly to three distributors in TN and NJ. Product may have been further distributed throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 3,096 bottles.
Why was this product recalled?
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Low. Recall number: D-0899-2023.